简体中文
繁體中文
English
Pусский
日本語
ภาษาไทย
Tiếng Việt
Bahasa Indonesia
Español
हिन्दी
Filippiiniläinen
Français
Deutsch
Português
Türkçe
한국어
العربية
Lời nói đầu:Mushroom's active ingredient is a drug called psilocybin, which has the potential to address conditions like anxiety and depression.
There's been a recent resurgence of interest in psychedelic drugs' potential to address conditions like anxiety and depression. Denver is set to become the first US city to decriminalize psychedelic mushrooms, after voters there approved a measure to direct police to make enforcing laws against them a low priority.Mushroom's active ingredient is a drug called psilocybin. Here's how it affects the body and brain.Visit Business Insider's homepage for more stories.In a slender and surprising victory for supporters of hallucinogenic or “magic” mushrooms, the psychedelic drug better known to scientists as psilocybin, Denver, Colorado yesterday voted to decriminalize the drugs.Once portrayed as illegal ways to “drop out” or “tune in,” psychedelic and semi-psychedelic drugs like psilocybin and ecstasy are beginning to turn into federally-regulated medicines. Part of the reason: scientific evidence is building that the substances may have the potential to help staunch symptoms of psychiatric diseases that are difficult to treat with existing therapies. Those diseases include severe depression, for example.Here's how psilocybin impacts the brain and body and produces its effects:
Miễn trừ trách nhiệm:
Các ý kiến trong bài viết này chỉ thể hiện quan điểm cá nhân của tác giả và không phải lời khuyên đầu tư. Thông tin trong bài viết mang tính tham khảo và không đảm bảo tính chính xác tuyệt đối. Nền tảng không chịu trách nhiệm cho bất kỳ quyết định đầu tư nào được đưa ra dựa trên nội dung này.
FP Markets
FOREX.com
AvaTrade
XM
Vantage
TMGM
FP Markets
FOREX.com
AvaTrade
XM
Vantage
TMGM
FP Markets
FOREX.com
AvaTrade
XM
Vantage
TMGM
FP Markets
FOREX.com
AvaTrade
XM
Vantage
TMGM